Dublin, April 19, 2022 (GLOBE NEWSWIRE) — The “Gene Editing Global Market Report 2022, By Technology, By End Users, By Application” report has been added to ResearchAndMarkets.com’s offering.
The global gene editing market is expected to grow from $5.41 billion in 2021 to $6.35 billion in 2022 at a compound annual growth rate (CAGR) of 17.2%. The market is expected to reach $12.04 billion in 2026 at a CAGR of 17.4%.
Rising infectious diseases acts as one of the major drivers of the gene editing market. Gene editing techniques are used for detection of infectious diseases such as HIV. Infectious diseases are caused by microorganisms like bacteria, viruses, fungi, and parasites. Gene therapy treats the infectious diseases by blocking the replication of the infectious agent that causes the disease at the extracellular level. Gene editing introduces new genetic material into the cells of living organisms with the intention of treating the diseases.
Infectious diseases are constantly on the rise. For instance, according to the World Health Organization (WHO), infectious diseases kill more than 17 million people per year. In addition to that, according to the AP-NORC (a research initiative by the Associated Press and the University of Chicago) survey, out of 1,067 adults in the US surveyed, 71% are in favor of gene editing for the treatment of incurable, hereditary diseases such as Huntington’s disease and 67% of Americans support the use of gene editing to prevent diseases…
